ProfileGDS4718 / 212137_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 96% 94% 96% 95% 94% 97% 97% 95% 94% 95% 95% 93% 97% 96% 97% 96% 94% 94% 96% 94% 95% 94% 94% 94% 96% 95% 94% 97% 95% 97% 96% 97% 93% 94% 97% 97% 97% 95% 94% 95% 95% 96% 96% 97% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]10.60396
GSM549102patient 115, normal, homogenized [OPG study]10.013194
GSM549104patient 119, normal, homogenized [OPG study]10.451396
GSM549108patient 138, normal, homogenized [OPG study]10.087195
GSM549119patient 077, normal, homogenized [OPG study]10.16594
GSM549133patient 032, cancer, homogenized [OPG study]11.026497
GSM549139patient 042, cancer, homogenized [OPG study]10.763297
GSM549099patient 107, normal, homogenized [OPG study]10.111195
GSM549109patient 139, normal, homogenized [OPG study]9.9466494
GSM549110patient 046, normal, homogenized [OPG study]10.346395
GSM549114patient 063, normal, homogenized [OPG study]10.40195
GSM549122patient 082, normal, homogenized [OPG study]9.7337393
GSM549134patient 033, cancer, homogenized [OPG study]11.032197
GSM549136patient 036, cancer, homogenized [OPG study]10.424296
GSM549140patient 044, cancer, homogenized [OPG study]10.783397
GSM549111patient 047, normal, homogenized [OPG study]10.557396
GSM549113patient 057, normal, homogenized [OPG study]10.213294
GSM549132patient 031, cancer, homogenized [OPG study]9.8927594
GSM549137patient 038, cancer, homogenized [OPG study]10.477696
GSM549142patient 047, cancer, homogenized [OPG study]9.5864794
GSM549100patient 110, normal, homogenized [OPG study]10.248595
GSM549107patient 135, normal, homogenized [OPG study]10.186594
GSM549115patient 068, normal, homogenized [OPG study]10.108894
GSM549116patient 072, normal, homogenized [OPG study]10.219294
GSM549120patient 078, normal, homogenized [OPG study]10.51496
GSM549131patient 030, cancer, homogenized [OPG study]10.33495
GSM549118patient 074, normal, homogenized [OPG study]10.126394
GSM549129patient 027, cancer, homogenized [OPG study]10.762197
GSM549123patient 088, normal, homogenized [OPG study]10.340495
GSM549124patient 006, cancer, homogenized [OPG study]10.84997
GSM549126patient 015, cancer, homogenized [OPG study]10.485596
GSM549128patient 025, cancer, homogenized [OPG study]11.019597
GSM549103patient 117, normal, homogenized [OPG study]9.795593
GSM549117patient 073, normal, homogenized [OPG study]10.190494
GSM549138patient 041, cancer, homogenized [OPG study]10.832397
GSM549141patient 045, cancer, homogenized [OPG study]11.094597
GSM549130patient 028, cancer, homogenized [OPG study]10.670897
GSM549101patient 111, normal, homogenized [OPG study]10.17795
GSM549105patient 128, normal, homogenized [OPG study]9.990294
GSM549106patient 134, normal, homogenized [OPG study]10.427795
GSM549112patient 048, normal, homogenized [OPG study]10.342395
GSM549125patient 011, cancer, homogenized [OPG study]10.33596
GSM549127patient 024, cancer, homogenized [OPG study]10.286496
GSM549135patient 035, cancer, homogenized [OPG study]11.10797